Exercise Training for Heart Disease
(EXCEED2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how two types of exercise training affect women with heart disease. The goal is to determine which type—high-intensity intervals or steady moderate exercise—improves exercise capacity more. Participants will exercise virtually twice a week for 12 weeks and report on their quality of life and health. Women who have undergone heart disease treatments or events at least four weeks ago and who aren't currently exercising regularly might be a good fit. As an unphased trial, this study offers a unique opportunity for participants to contribute to valuable research that could enhance exercise recommendations for women with heart disease.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these exercise training methods are safe for women with coronary heart disease?
Research has shown that both high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) are safe for people with heart disease. HIIT carries a low risk of major heart problems for those with coronary artery disease and can quickly enhance heart and lung fitness. Studies also indicate that patients tolerate HIIT well.
Similarly, MICT is safe and effective for individuals with coronary heart disease. Moderate exercise poses a low risk of heart issues and helps reduce the chances of heart disease and death.
Previous studies confirm that both exercise methods are safe for people with heart disease. They are often used in cardiac rehabilitation, a program designed to help heart patients improve their health.12345Why are researchers excited about this trial?
Researchers are excited about exercise training for heart disease because it offers a unique approach compared to traditional treatments like medications and lifestyle changes. High-intensity interval training (HIIT) introduces short bursts of intense effort, which could enhance cardiovascular fitness more efficiently than moderate-intensity continuous exercise. On the other hand, moderate-intensity continuous exercise provides a steady, sustained workout that may be easier for some patients to maintain. Both methods emphasize personalized heart rate targets, potentially leading to better patient outcomes and more tailored heart disease management.
What evidence suggests that this trial's exercise training treatments could be effective for heart disease?
This trial will compare two exercise interventions for heart disease: high-intensity interval training (HIIT) and moderate-intensity continuous exercise training (MICT). Research has shown that HIIT can be as effective, or even better, than MICT for improving fitness in people with coronary heart disease. Specifically, HIIT greatly improves heart health and boosts overall fitness, with a low rate of major heart-related issues. Meanwhile, MICT also provides similar benefits for quality of life and mental health as HIIT. Both exercise types can lower the risk of heart disease and enhance overall health.12345
Who Is on the Research Team?
Jennifer Reed, PhD
Principal Investigator
Ottawa Heart Institute Research Corporation
Are You a Good Fit for This Trial?
This trial is for women with coronary heart disease (CHD) who are interested in participating in a virtual exercise program. The study requires participants to train twice a week for 12 weeks, but specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into either virtual HIIT or MICT and exercise twice a week for 12 weeks
Follow-up
Participants are monitored for changes in health measures and exercise capacity
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor